Invention Grant
US09346789B2 Combinations of AKT inhibitor compounds and abiraterone, and methods of use
有权
AKT抑制剂化合物与阿比特龙的组合及使用方法
- Patent Title: Combinations of AKT inhibitor compounds and abiraterone, and methods of use
- Patent Title (中): AKT抑制剂化合物与阿比特龙的组合及使用方法
-
Application No.: US14009316Application Date: 2012-03-30
-
Publication No.: US09346789B2Publication Date: 2016-05-24
- Inventor: Michelle Nannini , Deepak Sampath
- Applicant: Michelle Nannini , Deepak Sampath
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Viksnins Harris & Padys PLLP
- International Application: PCT/US2012/031679 WO 20120330
- International Announcement: WO2012/135759 WO 20121004
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D239/70 ; C07D403/12 ; A61K31/437 ; A61K31/496 ; A61K31/517 ; A61K31/58 ; A61K31/282 ; A61K31/337 ; A61K31/4188 ; A61K31/4745 ; A61K31/513 ; A61K31/704 ; A61K39/395 ; A61K31/436 ; A61K31/138 ; A61K31/4166 ; A61K31/495 ; A61K31/555 ; A61K31/7068 ; C07K16/40 ; A61K39/00
Abstract:
The invention provides a combination of a) a compound of Formula (Ia): or a pharmaceutically acceptable salt thereof, and b) abiraterone or a pharmaceutically acceptable salt thereof for the prophylactic or therapeutic treatment of a hyperproliferative disorder, such as cancer.
Public/Granted literature
- US20140256691A1 COMBINATIONS OF AKT INHIBITOR COMPOUNDS AND ABIRATERONE, AND METHODS OF USE Public/Granted day:2014-09-11
Information query
IPC分类:
